Variant report
Variant | esv1843775 |
---|---|
Chromosome Location | chr7:126527812-126531028 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs144987954 | chr7:126527814-126527815 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138718082 | chr7:126527849-126527850 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368071928 | chr7:126527853-126527854 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570746337 | chr7:126527931-126527932 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs149442355 | chr7:126528036-126528037 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553472989 | chr7:126528074-126528075 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571763906 | chr7:126528076-126528077 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535855703 | chr7:126528094-126528095 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs562684057 | chr7:126528123-126528124 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs184545926 | chr7:126528148-126528149 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575988869 | chr7:126528185-126528186 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543384455 | chr7:126528250-126528251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565150080 | chr7:126528262-126528263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577131610 | chr7:126528270-126528271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541178203 | chr7:126528271-126528272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559895371 | chr7:126528331-126528332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189992831 | chr7:126528345-126528346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548659667 | chr7:126528346-126528347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576189624 | chr7:126528357-126528358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563560061 | chr7:126528393-126528394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2021162 | chr7:126528455-126528456 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs552611228 | chr7:126528461-126528462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs570782805 | chr7:126528472-126528473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534894172 | chr7:126528505-126528506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546751620 | chr7:126528562-126528563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181673721 | chr7:126528606-126528607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184827535 | chr7:126528630-126528631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557095833 | chr7:126528632-126528633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2109739 | chr7:126528686-126528687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148148461 | chr7:126528721-126528722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575960544 | chr7:126528838-126528839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189981729 | chr7:126528844-126528845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558575800 | chr7:126528845-126528846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs577167644 | chr7:126528858-126528859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs78419376 | chr7:126528899-126528900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs377632361 | chr7:126528920-126528921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs561803778 | chr7:126528930-126528931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs181184210 | chr7:126528985-126528986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185492311 | chr7:126528987-126528988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564579558 | chr7:126528996-126528997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141090041 | chr7:126528998-126528999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs574662958 | chr7:126529023-126529024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527582370 | chr7:126529024-126529025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs528843299 | chr7:126529078-126529079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs541993450 | chr7:126529080-126529081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs563769324 | chr7:126529091-126529092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369687576 | chr7:126529143-126529144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530834260 | chr7:126529188-126529189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546132901 | chr7:126529201-126529202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546547760 | chr7:126529208-126529209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Autism | 20808228 | CNVD |
Cancer | 20164919 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Prostate cancer | 22341455 | CNVD |
Attention deficit hyperactivity disorder | 22138692 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:126527000-126529600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr7:126527600-126528000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr7:126527600-126528200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr7:126527600-126528600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr7:126527800-126528200 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr7:126527800-126528600 | Enhancers | Brain Anterior Caudate | brain |
7 | chr7:126528000-126528400 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr7:126528200-126528800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
9 | chr7:126528600-126529000 | Enhancers | Brain Germinal Matrix | brain |